Solving a mysterious inflammatory fever opens the book on a much bigger story

Three research teams from around the globe independently discovered that a single molecular interaction inside our cells controls a range of inflammatory diseases. This breakthrough solved a decades-old mystery surrounding Familial Mediterranean Fever (FMF), the most common inherited autoinflammatory disease, which affects 1-2 people per 1,000 in populations from Mediterranean, Middle Eastern, Armenian and Jewish backgrounds. FMF primarily manifests in childhood with recurring fevers, painful rashes, and joint pain.

The research team, comprising scientists from the Hudson Institute of Medical Research, Monash Health, and collaborators in South Korea and the U.S., identified a genetic mutation in the CDC42 gene as the cause. This mutation alters the CDC42 protein, causing it to bind tightly to pyrin, another protein that functions like a smoke detector for the immune system. In individuals with this mutation, pyrin is activated too frequently, leading to excessive inflammation, fever, pain, and rash.

Treatment for this condition is straightforward: administering anakinra, a drug that blocks the specific inflammatory signal. The symptoms of FMF vanished almost immediately after treatment began. The researchers published their findings in the journal Science Immunology, revealing that this same CDC42-pyrin interaction is a master switch for a spectrum of inflammatory diseases.

Interestingly, two other independent studies found that similar CDC42 mutations in different families caused the same symptoms, suggesting a new category of related diseases. This discovery opens the door for recognizing and treating these conditions more effectively. The CDC42-pyrin interaction represents a fundamental mechanism behind inflammatory diseases, bridging ancient and modern afflictions.